Monthly Newsletter

Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and Hamamatsu Photonics K.K., a forerunner in whole slide imaging systems, announced an agreement to maintain long-term interoperability between Indica Lab’s HALO AP® software platform and Hamamatsu’s NanoZoomer family of high-speed, high-resolution scanners.

Indica Lab's browser-based, CE-marked^* HALO AP® software brings case-centric digital pathology slide management, collaboration, and AI-powered quantitative image analysis to Anatomic Pathology labs worldwide. In keeping with Indica Lab's ethos of an accessible and open pathology ecosystem, HALO AP is scanner agnostic and integrates with a variety of third-party software applications, including AI solutions and LIS/LIMS platforms, using flexible, easy-to-use APIs and software development kit (SDK).

Hamamatsu brings over 60 years of photonics engineering to bear on the development of NanoZoomer scanners, resulting in instruments that are renowned for image quality, reliability, and ease of use. When coupled with Hamamatsu’s dedication to customer service, Hamamatsu users experience the best combination of robust performance and personalized support.

As laboratories adopt digital solutions, the challenge for laboratory managers is to integrate an array of hardware and software and achieve maximum efficiency. This collaboration between Indica Labs and Hamamatsu streamlines this process.

"Providing interoperability and scalable solutions is critical to the adoption of digital pathology." commented Don Ariyakumar, NanoZoomer Product Manager at Hamamatsu. "We believe that customers should be able to choose best-of-class products. The option to implement the most appropriate hardware and software for their specific needs increases the value of digital pathology for all stakeholders."

Hamamatsu's technical collaboration with Indica Labs will facilitate Indica Labs approach to regulatory clearances utilizing the HALO AP system in conjunction with the NanoZoomer S360MD^* for primary diagnosis. Ongoing technical performance assessments to verify that Hamamatsu’s image format is accurately displayed in all Indica Labs’ viewers guarantees continued interoperability of Indica and Hamamatsu products and will help drive the adoption of these technologies within the pathology community.

Indica Labs' CEO, Steven Hashagen commented "This agreement is an important reassurance to our mutual customers that both companies are committed to working together on technical, regulatory, and commercial fronts. It ensures we can achieve image fidelity and interoperability across our viewing and analysis software, allows us to align our regulatory submissions, and facilitates sales and support cooperation for our mutual customers as we have demonstrated in the past."

The relationship between Indica Labs and Hamamatsu resulted in the win of significant digital pathology tenders in the United Kingdom, most notably Nottingham University Hospitals (NUH ) NHS Trust. NUH is the third largest NHS Trust in the United Kingdom, serving over 2.5 million patients, and generating 340,000 pathology slides per year. The goal of the NUH implementation is full digitization of the pathology workflow. Read further details of the NUH NHS Trust HALO AP and NanoZoomer implementation here https://indicalab.com/news/press-release-nuh-nhs-trust-selects-indica-labs-halo-ap-as-digital-pathology-solution/.

About Indica Labs, Inc

Indica Labs is the world's leading provider of computational pathology software and services. Our flagship HALO® image analysis platformenables fast, quantitative evaluation of tissues using a broad range of artificial intelligence (AI) and computer vision algorithms. HALO Link and HALO AP facilitates remote image analysis, collaboration and management. Through a combination of precision, scalability, and usability our software solutions enable pharmaceutical companies, diagnostic labs, research organizations, and Indica's own contract pharma services team to advance tissue-based research, clinical trials, and diagnostics

About Hamamatsu Photonics K.K.

Hamamatsu Photonics K.K. is a global leader in the design and manufacturing of photonics devices, including advanced imaging detectors for medical, environmental, biological, and semi-conductor industries. Our optical sensors, light sources, cameras, photometry systems, and measurement/analysis systems provide critical photonics components in a wide variety of demanding applications and markets. Our NanoZoomer line of digital scanners has been a trailblazer in whole slide imaging scanner technology for pathology research for over two decades.

^* HALO AP is CE-IVD marked for use in primary diagnosis within the European Economic Area, Switzerland, and the UK and is For Research Use Only in the US.

^* Intended use of the product is: NanoZoomer S360MD Slide scanner system ("NanoZoomer System") is an automated digital slide creation, viewing, and management system. The NanoZoomer System is intended for in vitro diagnostic use as an aid to the pathologist to review and interpret digital images of surgical pathology slides prepared from formalin-fixed paraffin embedded ("FFPE") tissue. The NanoZoomer System is not intended for use with frozen section, cytology, or non-FFPE hematopathology specimens.

The NanoZoomer System comprises the NanoZoomer S360MD Slide scanner, the NZViewMD Software and the JVC Kenwood JD-C240BN01A display. The NanoZoomer System is for creation and viewing of digital images of scanned glass slides that would otherwise be appropriate for manual visualization by conventional light microscopy. It is the responsibility of a qualified pathologist to employ appropriate procedures and safeguards to assure the validity of the interpretation of images obtained using NanoZoomer System.